Gallic acid, a common dietary phenolic protects against high fat diet induced DNA damage.
DNA damage
Gallic acid
High fat diet
Inflammation
Obesity
Journal
European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
27
04
2018
accepted:
15
07
2018
pubmed:
25
7
2018
medline:
13
2
2020
entrez:
25
7
2018
Statut:
ppublish
Résumé
Aim of the study was to find out if gallic acid (GA), a common phenolic in plant foods, prevents obesity induced DNA damage which plays a key role in the induction of overweight associated cancer. Male and female C57BL6/J mice were fed with a low fat or a high fat diet (HFD). The HFD group received different doses GA (0, 2.6-20 mg/kg b.w./day) in the drinking water for 1 week. Subsequently, alterations of the genetic stability in blood and inner organs were monitored in single cell gel electrophoresis assays. To elucidate the underlying molecular mechanisms: oxidized DNA bases, alterations of the redox status, lipid and glucose metabolism, cytokine levels and hepatic NF-κB activity were monitored. HFD fed animals had higher body weights; increased DNA damage and oxidation of DNA bases damage were detected in colon, liver and brain but not in blood and white adipose tissue. Furthermore, elevated concentrations of insulin, glucose, triglycerides, MCP-1, TNF-α and NF-κB activity were observed in this group. Small amounts of GA, in the range of human consumption, caused DNA protection and reduced oxidation of DNA bases, as well as biochemical and inflammatory parameters. Obese animals have increased DNA damage due to oxidation of DNA bases. This effect is probably caused by increased levels of glucose and insulin. The effects of GA can be explained by its hypoglycaemic properties and indicate that the consumption of GA-rich foods prevents adverse health effects in obese individuals.
Identifiants
pubmed: 30039436
doi: 10.1007/s00394-018-1782-2
pii: 10.1007/s00394-018-1782-2
pmc: PMC6689278
doi:
Substances chimiques
Dietary Fats
0
Gallic Acid
632XD903SP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2315-2326Subventions
Organisme : Fonds zur Förderung der wissenschaftlichen Forschung (FWF)
ID : AP2658721
Références
Environ Mol Mutagen. 2000;35(3):206-21
pubmed: 10737956
Diabetes Care. 2000 Sep;23(9):1442-3
pubmed: 10977056
Arch Toxicol. 2002 Jan;75(11-12):685-94
pubmed: 11876501
Mutat Res. 2002 Aug 26;519(1-2):103-19
pubmed: 12160896
Diabetes. 2003 Aug;52(8):1958-66
pubmed: 12882911
J Lipid Res. 2003 Dec;44(12):2356-64
pubmed: 12951360
Diabetes. 2003 Nov;52(11):2795-804
pubmed: 14578299
Mol Biotechnol. 2004 Mar;26(3):249-61
pubmed: 15004294
Nat Rev Cancer. 2004 Aug;4(8):579-91
pubmed: 15286738
J Clin Invest. 2004 Dec;114(12):1752-61
pubmed: 15599400
Br J Nutr. 2007 Oct;98(4):727-35
pubmed: 17475086
Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1297-302
pubmed: 18216263
Br J Nutr. 2008 May;99 E Suppl 1:ES3-52
pubmed: 18503734
Chem Biol Interact. 2008 Jul 30;174(2):109-17
pubmed: 18571153
Atherosclerosis. 2009 Feb;202(2):382-93
pubmed: 18599066
Mol Biol Rep. 2010 Jan;37(1):289-95
pubmed: 19669594
Genes Nutr. 2009 Sep;4(3):215-22
pubmed: 19707810
N Engl J Med. 2009 Oct 8;361(15):1475-85
pubmed: 19812404
FEBS Lett. 2010 Feb 5;584(3):531-6
pubmed: 19962377
Cancer Res. 1991 Apr 1;51(7):1789-92
pubmed: 2004363
Diabetes. 1991 Apr;40(4):405-12
pubmed: 2010041
Mol Genet Metab. 2010 Oct-Nov;101(2-3):273-8
pubmed: 20729114
FASEB J. 2011 Feb;25(2):685-93
pubmed: 21068397
Chem Biol Interact. 2011 Jan 15;189(1-2):112-8
pubmed: 21078310
Cell Res. 2011 Jan;21(1):103-15
pubmed: 21187859
J Biochem Mol Toxicol. 2011 Mar-Apr;25(2):68-76
pubmed: 21472896
Mutat Res. 2011 Oct 1;715(1-2):61-71
pubmed: 21827773
Methods Mol Biol. 2012;821:421-33
pubmed: 22125082
Pharm Stat. 2011 Nov-Dec;10(6):485-93
pubmed: 22127874
Mol Med Rep. 2012 Oct;6(4):815-20
pubmed: 22858825
Endocrinology. 2013 Apr;154(4):1434-43
pubmed: 23456362
Br J Nutr. 2013 Oct;110(8):1500-11
pubmed: 23507418
FASEB J. 2013 Aug;27(8):3323-34
pubmed: 23603834
Clinics (Sao Paulo). 2013;68(3):385-9
pubmed: 23644860
J Cereb Blood Flow Metab. 2013 Nov;33(11):1778-88
pubmed: 23881248
Scand J Clin Lab Invest. 2013 Dec;73(8):607-14
pubmed: 24219649
Mutat Res. 2014 Dec;770:144-52
pubmed: 24296107
Free Radic Biol Med. 2014 Mar;68:247-57
pubmed: 24355212
Methods Enzymol. 2014;537:93-122
pubmed: 24480343
Adv Exp Med Biol. 2014;824:5-17
pubmed: 25038989
Front Genet. 2014 Aug 25;5:288
pubmed: 25202323
Nutrition. 2014 Nov-Dec;30(11-12):1398-403
pubmed: 25280419
Mutat Res Genet Toxicol Environ Mutagen. 2014 Sep 1;771:30-6
pubmed: 25308439
Endocrinology. 2015 Jan;156(1):157-68
pubmed: 25356824
Mutagenesis. 2015 Jan;30(1):155-63
pubmed: 25527738
Steroids. 2015 Apr;96:1-6
pubmed: 25554578
Sci Rep. 2015 Nov 13;5:16474
pubmed: 26563579
Cell Metab. 2016 Jan 12;23(1):48-62
pubmed: 26771116
Free Radic Biol Med. 2016 May;94:208-17
pubmed: 26939878
J Basic Clin Pharm. 2016 Mar;7(2):27-31
pubmed: 27057123
Int J Impot Res. 2016 Jul;28(4):148-54
pubmed: 27076112
Andrology. 2016 Nov;4(6):1102-1114
pubmed: 27575329
Environ Mol Mutagen. 2016 Dec;57(9):668-677
pubmed: 27739633
Obesity (Silver Spring). 2016 Nov;24(11):2301-2310
pubmed: 27804267
Oxid Med Cell Longev. 2017;2017:3079148
pubmed: 28133504
Nutrients. 2017 Jun 14;9(6):null
pubmed: 28613268
Mol Nutr Food Res. 2018 Feb;62(4):
pubmed: 29193677
Diabetes. 1993 Jun;42(6):801-13
pubmed: 8495803
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Z Ernahrungswiss. 1998 Jun;37(2):190-7
pubmed: 9698647